NIGHT Monthly

$81.00 / month

Anresco Labs COA** FMCNGT1019

Dosage: Night Capsules contain 3mg THC (no CBD) and 2mg of Melatonin in each capsule.
Packaging: Pill Cards of 30 capsules, each that contain a total of 150mg of combined cannabinoids, with a modified THC formulation (less psychoactive effect).

Ideal for: Patients seeking relief from insomnia.

* Product prices include all taxes, fees & delivery

Category:

Description

NIGHT – THC/MELATONIN

Dosage: Night Capsules contain 3mg THC (no CBD) and 2mg of Melatonin in each capsule.
Packaging: Pill Cards of 30 capsules, each that contain a total of 150mg of combined cannabinoids, with a modified THC formulation (less psychoactive effect).

Ideal for: Patients seeking relief from insomnia.

OUR CAPSULES (CAPS) each contain a specific, consistent cannabinoid dosage including a proprietary balance of natural terpene extracts. Capsules are then packaged, labeled and batch tested for accuracy, potency and potential contaminants. Delivery consists of a child-resistant zip bag containing a pharmacy style blister Pill Card, including patient-specific labels.

Whether you are a doctor, caregiver, care facility director or patient, you can be confident Farmacann products always meet or exceed the manufacturing, testing and regulatory requirements of the State of California, Medical Professionals and Licensed Care Facilities and every batch of each product receives a COA** from Anresco Laboratories in San Francisco, an industry leader since 1943, ISO 17025 accredited, FDA registered, and ELAP certified.

** A Certificate of Analysis, or COA, is a document issued by a third-party, independent testing laboratory that confirms a product meets its specification, including quantity of cannabinoids and terpenes found in each product as well as confirming that each product does not contain harmful heavy metals, pesticides, solvents, and pathogens.

Sign up for the Farmacann Newsletter

Sign up to know about all of our educational events, learn about relevant medical cannabis news and the latest research that impacts our community.

We don’t spam! Read our privacy policy for more info.